Panagiotis D. Tsirigotis

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Validation of the new IMS/IMWG consensus genomic staging (CGS) of high-risk multiple myeloma (HRMM) in a contemporary cohort of 1209 patients.

Validation of the new IMS/IMWG consensus genomic staging (CGS) of high-risk multiple myeloma (HRMM) in a contemporary cohort of 1209 patients.

Journal: HemaSphere

Published: March 09, 2026

Single-Agent Selinexor Versus Physician's Choice in Previously Treated Myelofibrosis: Results From the Phase 2 XPORT-035 Study.

Single-Agent Selinexor Versus Physician's Choice in Previously Treated Myelofibrosis: Results From the Phase 2 XPORT-035 Study.

Journal: EJHaem

Published: February 18, 2026

Gilteritinib for Prevention of Post-transplant Relapse in Patients With Acute Myeloid Leukemia and FLT3-ITD Mutation: Real-Life Data from Two Centers.

Gilteritinib for Prevention of Post-transplant Relapse in Patients With Acute Myeloid Leukemia and FLT3-ITD Mutation: Real-Life Data from Two Centers.

Journal: Transplantation and cellular therapy

Published: February 05, 2026

Real-World Outcomes in NPM1-Mutated Acute Myeloid Leukemia: The Impact of Measurable Residual Disease on Disease Relapse.

Real-World Outcomes in NPM1-Mutated Acute Myeloid Leukemia: The Impact of Measurable Residual Disease on Disease Relapse.

Journal: American journal of hematology

Published: January 30, 2026

Rectal Colonization with Multidrug-Resistant Organisms and Subsequent Bloodstream Infections in Hematological Patients Undergoing Cellular Therapies.

Rectal Colonization with Multidrug-Resistant Organisms and Subsequent Bloodstream Infections in Hematological Patients Undergoing Cellular Therapies.

Journal: Transplantation and cellular therapy

Published: January 09, 2026

Characteristics and clinical course of younger patients with asymptomatic monoclonal gammopathies.

Characteristics and clinical course of younger patients with asymptomatic monoclonal gammopathies.

Journal: British journal of haematology

Published: November 25, 2025

Patient With Bilateral Infracts and Vasculitis With Graft vs Host Disease.

Patient With Bilateral Infracts and Vasculitis With Graft vs Host Disease.

Journal: Neurology

Published: September 18, 2025

Clinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centre.

Clinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centre.

Journal: British journal of haematology

Published: September 15, 2025

Low-dose post-transplant cyclophosphamide in combination with low-dose alemtuzumab for graft-versus-host-disease prevention in mismatched unrelated allogeneic stem cell transplantation is associated with improved outcomes and reduced toxicity.

Low-dose post-transplant cyclophosphamide in combination with low-dose alemtuzumab for graft-versus-host-disease prevention in mismatched unrelated allogeneic stem cell transplantation is associated with improved outcomes and reduced toxicity.

Journal: Bone marrow transplantation

Published: August 16, 2025

Donor-derived malignancy after allogeneic stem cell transplantation: a rare but well recognized complication.

Donor-derived malignancy after allogeneic stem cell transplantation: a rare but well recognized complication.

Journal: Bone marrow transplantation

Published: April 16, 2025

Caplacizumab as an Emerging Treatment for Patients With Thrombotic Thrombocytopenic Purpura Presenting With Acute Ischemic Stroke.

Caplacizumab as an Emerging Treatment for Patients With Thrombotic Thrombocytopenic Purpura Presenting With Acute Ischemic Stroke.

Journal: Neurology. Clinical practice

Published: March 20, 2025

Validation of the simplified geriatric prognostic index in a Hellenic database of older patients (≥ 70 years old) with diffuse large B-cell lymphoma and similar disorders.

Validation of the simplified geriatric prognostic index in a Hellenic database of older patients (≥ 70 years old) with diffuse large B-cell lymphoma and similar disorders.

Journal: Annals of hematology

Published: January 08, 2025

Showing 1-12 of 92

Last Updated: 09/26/2026